Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

October 2012 · Vol. 24, No. 10

EXAMINING THE EVIDENCE

Does treatment of cervical
intraepithelial neoplasia always
increase the risk of preterm birth
in subsequent gestations?

No. In this retrospective-prospective cohort study from England, the risk of preterm delivery in women treated for cervical intraepithelial neoplasia (CIN) was significantly lower than the risk reported in many other studies. In fact, after investigators adjusted for confounding factors, the increased risk of preterm delivery after treatment for CIN ceased to exist.

Castanon A, Brocklehurst P, Evans H, et al; PaCT Study Group. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study. BMJ. 2012;345:e5174. doi: 10.1136/bmj.e5174.

EXPERT COMMENTARY

Andrew M. Kaunitz, MD

Professor and Associate Chairman, Department of ObGyn, University of Florida College of Medicine–Jacksonville. Dr. Kaunitz serves on the OBG Management Board of Editors.



Several studies have suggested that the risk of preterm birth increases after treatment for CIN. For example, a meta-analysis of 27 studies found a relative risk (RR) of preterm delivery of 1.70 after treatment for CIN (95% confidence interval [CI], 1.24–2.35).1 Later studies from Nordic countries estimated the RR at 1.8 to 2.8.2,3

CLICK HERE to read more


Advertisement



Advertisement1


XMLRSS callout
 

Advertisement